Marathon Bancorp heads into its May 19 earnings call with short sellers backing away hard and the stock quietly building one of its best multi-week runs of the year.
The short-side retreat is the clearest story in the data. Short interest has fallen nearly 28% over the past week, dropping to roughly 0.31% of the free float — a level so low it barely registers as a bearish signal. What makes the move striking is the context: as recently as late April, short interest had surged to its one-month peak, with borrowing conditions tightening noticeably and availability at its tightest. That spike has since fully unwound. Borrow availability is now extremely loose at over 3,200% of short interest, meaning shares are in plentiful supply for anyone still looking to short. Cost to borrow, at 3.92%, has eased from a late-April high above 5% and drifted gently lower across the past month. The ORTEX short score has dropped from around 40.5 on April 30 — its recent high — to 30.1 today, a sharp fall that signals substantially reduced bearish conviction in the lending market.
The price action reflects that shift. MBBC gained 3.3% on the week and 14.2% on the month, closing at $15.13. That puts the stock up roughly 24% year-to-date. RSI14 of 57 is constructive without being overbought — there is no sign of froth in the technical picture. The micro-cap market cap of around $44 million means the stock can move meaningfully on thin volume, and the one-month appreciation is substantial enough to have likely forced some of the short covering now showing in the data.
Institutional ownership is a standout feature for a bank of this size. The top three holders together account for nearly 19% of shares, with AllianceBernstein adding 20,000 shares in Q4 2025 and Maltese Capital — a known community-bank activist — adding 10,000 shares over the same period. Vanguard reported a significant addition of over 57,000 shares as of March 31, 2026. That's a notably concentrated ownership structure for a sub-$50 million market cap lender, with specialist small-bank investors clearly interested. Insider data is stale beyond the 90-day window, so the most recent on-record trades — CEO Nicholas Zillges buying in November 2025 around $11 — provide context rather than a current signal.
Earnings history is modest in terms of reaction. The last four prints produced day-one moves of -1.8%, -1.4%, +1.9%, and -0.5%. The five-day windows were similarly contained, with the exception of a +5.6% move following the November 2025 release. None of these qualify as high-volatility events for the stock. Closest Nasdaq-listed peer CHMG slipped 0.8% on the week while MBBC advanced, a small but notable divergence among regional bank comparables.
With Q3 2026 results now scheduled for May 19, the key question is whether the recent short-covering wave reflects informed positioning ahead of the print — or simply a drift back to baseline in a thinly traded name.
See the live data behind this article on ORTEX.
Open MBBC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
